Good smells and bright light are good "medicine" for people with dementiaAugust 18, 2003Aromatherapy and bright light therapy can reduce symptoms such as agitation and sleep disturbances and improve the quality of life for people with Alzheimer's disease and other dementias, according to information presented here today at the 11th Congress of the International Psychogeriatric Association (IPA). The addition of these alternative medicine techniques to treatment plans also may improve the quality of life for caregivers, researchers reported. Bright Light Therapy "Patients who sat in front of a bright light box for two hours each morning for two weeks slept longer and more deeply than people who sat in front of dim light for the same period of time," said E. Jane Byrne, MRCP, department of old age psychiatry, Manchester Royal Infirmary, Manchester, United Kingdom. The benefits of bright light were significantly greater in the winter months when the days are shorter and people are exposed to less sunlight. Patients in the study, which was supported by the Mental Health Foundation, UK, included 48 nursing home residents diagnosed with Alzheimer's or other diseases that cause memory loss, dementia, or mental confusion. The overall duration of sleep and patients' level of activity during sleep - or "tossing and turning" - were measured with wristwatch-like devices called "actigraphs" that were worn by the patients in the study. "Ours is the largest randomized, placebo-controlled study to demonstrate the benefits of bright light to improve symptoms of Alzheimer's and similar diseases and make life more comfortable for patients and the people who take care of them, and the first to show that this effect is greatest in the winter when there is less natural sunlight," said Harry Allen, MRCP, consultant psychiatrist at Manchester Royal Infirmary and co-author of the study. "Sometimes, the ability to control these symptoms can make the difference between being able to keep a loved one at home or institutionalization," he said. Lightboxes that gave off 100,000 lux of light were used in the study. "Light boxes such as the ones we used are widely available and cost approximately $150," Dr. Allen said. For people who cannot afford the boxes, Dr. Allen recommends planning daily activities, such as breakfast or other meals, during the brightest parts of the day and in areas where patients are facing a window; and having daily outings to parks, gardens or even the front porch or back yard during the sunniest times of day and in places that get the most sun. "Most of us have had the experience of feeling our mood improve when we are exposed to bright sunlight," Dr. Allen said. "Too often we shut people with dementia up in dark rooms with little opportunity to see the sun or other bright light, which can make their symptoms worse." Aromatherapy In a related presentation, researchers found that aromatherapy with Melissa balm significantly improved agitation in people with severe dementias. In the randomized, placebo-controlled trial, 72 nursing home residents who suffered frequent bouts of agitation due to severe dementia were divided into two groups. One group was exposed to lemon balm, an essential oil that was applied in a base cream by brief massage; while sunflower oil, an odorless substance, was used for the second group. " Over a four-week period of treatment, 35 percent of patients in the lemon balm group showed an overall improvement in agitation, compared to 11 percent in the placebo group," said Professor Clive Ballard, University of Newcastle, Newcastle upon Tyne, United Kingdom. "Patients exposed to lemon balm also showed significant improvements in the quality of life, including a decrease in social withdrawal and an increase in constructive activities. Snell Communications Ltd |
|||||||||||||||||||||
| Related Alzheimer Disease Current Events and Alzheimer Disease News Articles Delirium in hospitalized adults: Situation critical, no relief available Every year as many as seven million adults in the United States experience delirium during hospitalization. New data demonstrate potential for early detection of Alzheimer's disease Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease. Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH). Measuring brain atrophy in patients with mild cognitive impairment Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease. Commonly used medications may produce cognitive impairment in older adults Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults. Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug. New test for mysterious metabolic diseases developed at Stanford/Packard Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells' fuel-burning mechanism. Recalibrating 'fight or flight' A Canadian/U.S. research team has reported a novel approach to stimulating recovery from chronic stress disorders. Details of the therapeutic model, which exploits the natural dynamics of the body's "fight or flight" system, are published January 23 in the open-access journal PLoS Computational Biology Vitamin B does not slow cognitive decline in Alzheimer's A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. Protecting patient privacy the new fashioned way Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act. More Alzheimer Disease Current Events and Alzheimer Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||